InvestorsHub Logo

hopester

05/06/20 5:55 PM

#2662 RE: AMOTE1 #2661

While ARDS has dominated the news, lets not overlook the potential success ATHX could have for their trials for Ischemic Stroke which has been in the later stages of the "PHASES".
Just that could be a blockbuster.